71 Results for "

kainate

" in MedChemExpress (MCE) Product Catalog:
Products (71)

71 Results for "kainate" in MCE Product Catalog:

32
32 Publications Verification
Cat. No.: HY-B1102
CAS No.: 314-13-6
Synonyms: Direct Blue 53; T-1824; C.I. 23860
Evans Blue (Direct Blue 53) is a potent inhibitor of L-glutamate uptake via the membrane bound excitatory amino acid transporter (EAAT). Evans Blue is a L-glutamate and kainate receptor-mediated currents inhibitor. Evans Blue has a strong affinity towards serum albumin, making it a high molecular weight protein tracer. Evans Blue is also used to study BBB (blood-brain barrier) permeability .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-15066
CAS No.: 115066-14-3
Purity:  99.38%
Synonyms: FG9065
Target:  

iGluR

Research Areas:  

Neurological Disease

CNQX (FG9065) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. CNQX is a competitive non-NMDA receptor antagonist . CNQX blocks the expression of fear-potentiated startle in rats .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-15066A
CAS No.: 479347-85-8
Purity:  99.95%
Synonyms: FG9065 disodium
Target:  

iGluR

Research Areas:  

Neurological Disease

CNQX disodium (FG9065 disodium) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. CNQX disodium is a competitive non-NMDA receptor antagonist . CNQX disodium blocks the expression of fear-potentiated startle in rats .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15067
CAS No.: 2379-57-9
Purity:  99.26%
Synonyms: FG 9041
Target:  

iGluR

Research Areas:  

Cancer

DNQX (FG 9041), a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively) .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-103233
CAS No.: 1312992-24-7
Synonyms: FG 9041 disodium salt
Target:  

iGluR

Research Areas:  

Cancer

DNQX (FG 9041) disodium salt, a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively) .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-B0122
CAS No.: 97240-79-4
Synonyms: McN 4853; RWJ 17021
Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101165
CAS No.: 2259-96-3
Purity:  98.29%
Target:  

iGluR GABA Receptor

Research Areas:  

Neurological Disease

Cyclothiazide is a positive allosteric modulator of ionotropic AMPA-type glutamate receptors. Cyclothiazide inhibits GABAA receptors. Cyclothiazide is frequently used to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current. Cyclothiazide can potentiate responses to kainate in hippocampal neurons. Cyclothiazide has effects on glutamatergic neurotransmission. Cyclothiazide also induces epileptiform EEG activity accompanying behavioral seizures .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14608S5
CAS No.: 55443-55-5
Purity:  ≥98.0%
L-Glutamic acid- 13C5 is the 13C-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100834
CAS No.: 131123-76-7
Purity:  99.98%
Synonyms: 5,7-DCKA
Target:  

iGluR

Research Areas:  

Neurological Disease

5,7-Dichlorokynurenic acid (5,7-DCKA) is a selective and competitive antagonist of the glycine site on NMDA receptor with a KB of 65 nM. 5,7-Dichlorokynurenic acid reduces NMDA-induced neuron injury. 5,7-Dichlorokynurenic acid increases social interaction time, increases open arm exploration time, disinhibits suppressed conflict responding in rodent models. 5,7-Dichlorokynurenic acid exhibits anxiolytic-like activity in rodent models and supports exploration of glycine’s role in NMDA receptor-mediated synaptic transmission .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15069
CAS No.: 161605-73-8
Purity:  99.34%
Synonyms: ZK200775; MPQX
Target:  

iGluR

Research Areas:  

Neurological Disease

Fanapanel (ZK200775) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114427
CAS No.: 136623-01-3
Purity:  98.00%
Target:  

iGluR

Research Areas:  

Neurological Disease

NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18663
CAS No.: 199655-36-2
Target:  

iGluR

Research Areas:  

Neurological Disease

CP-465022 is a potent, and selective noncompetitive AMPA receptor antagonist with anticonvulsant activity. CP-465022 is against Kainate-induced response with an IC50 of 25 nM in rat cortical neurons. CP-465022 provides a new tool to investigate the role of AMPA receptors in physiological and pathophysiological processes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15069A
CAS No.: 1255517-78-2
Purity:  99.76%
Synonyms: ZK200775 hydrate; MPQX hydrate
Target:  

iGluR

Research Areas:  

Neurological Disease

Fanapanel hydrate (ZK200775 hydrate) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107604
CAS No.: 745055-91-8
Purity:  99.75%
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP 302 is a potent and selective GLUK5-subunit containing kainate receptor antagonist (apparent Kd=402 nM), and displays very little affinity on GluK2 (GluR6) kainate receptors. Anxiolytic effects .
loading...
    loading...
Cat. No.: HY-14608S7
CAS No.: 2784-50-1
Purity:  99.8%
L-Glutamic acid-d5 is the deuterium labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-14608S8
CAS No.: 203805-84-9
Purity:  98.00%
L-Glutamic acid-d3 is the deuterium labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-107601
CAS No.: 936095-50-0
Purity:  99.95%
Synonyms: ACET
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist .
loading...
    loading...
Cat. No.: HY-14608S3
CAS No.: 202468-31-3
Purity:  99.9%
L-Glutamic acid- 13C5, 15N is the 13C- and 15N-labeled L-Glutamic acid. L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
loading...
    loading...
Cat. No.: HY-101310
CAS No.: 31137-74-3
Purity:  ≥98.0%
SYM 2081 is a kainate receptor agonist. SYM 2081 is a substrate of EAAT1 (Km of 54 μM). SYM 2081 inhibits EAAT2-mediated glutamate transport (Kb is 3.4 μM in Xenopus oocytes), modulates Apoptotic signaling pathways (increases Bcl-2 and decreases Bax/caspase-3 expression). SYM 2081 exhibits neuroprotective activity. SYM 2081 can be used in the study of hypoxic-ischemic brain damage and inflammatory or neuropathic pain .
loading...
    loading...
Cat. No.: HY-103234A
CAS No.: 2319722-40-0
Purity:  99.75%
Target:  

iGluR

Research Areas:  

Neurological Disease

GYKI 52466 dihydrochloride is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively. GYKI 52466 dihydrochloride has good blood brain barrier permeability and anticonvulsant effect. GYKI 52466 dihydrochloride can be used in Parkinson's disease research .
loading...
    loading...